These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28414308)

  • 1. Complex regulation of LCoR signaling in breast cancer cells.
    Jalaguier S; Teyssier C; Nait Achour T; Lucas A; Bonnet S; Rodriguez C; Elarouci N; Lapierre M; Cavaillès V
    Oncogene; 2017 Aug; 36(33):4790-4801. PubMed ID: 28414308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report.
    Müller K; Sixou S; Kuhn C; Jalaguier S; Mayr D; Ditsch N; Weissenbacher T; Harbeck N; Mahner S; Cavaillès V; Jeschke U
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression.
    Palijan A; Fernandes I; Verway M; Kourelis M; Bastien Y; Tavera-Mendoza LE; Sacheli A; Bourdeau V; Mader S; White JH
    J Biol Chem; 2009 Oct; 284(44):30275-87. PubMed ID: 19744932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.
    Vogelsang TLR; Schmoeckel E; Kuhn C; Blankenstein T; Temelkov M; Heidegger H; Kolben TM; Kolben T; Mahner S; Mayr D; Jeschke U; Vattai A
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1847-1855. PubMed ID: 32157438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.
    Sixou S; Müller K; Jalaguier S; Kuhn C; Harbeck N; Mayr D; Engel J; Jeschke U; Ditsch N; Cavaillès V
    Transl Oncol; 2018 Oct; 11(5):1090-1096. PubMed ID: 30007204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-interacting protein 140 is a repressor of the androgen receptor activity.
    Carascossa S; Gobinet J; Georget V; Lucas A; Badia E; Castet A; White R; Nicolas JC; Cavaillès V; Jalaguier S
    Mol Endocrinol; 2006 Jul; 20(7):1506-18. PubMed ID: 16527872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms.
    Fernandes I; Bastien Y; Wai T; Nygard K; Lin R; Cormier O; Lee HS; Eng F; Bertos NR; Pelletier N; Mader S; Han VK; Yang XJ; White JH
    Mol Cell; 2003 Jan; 11(1):139-50. PubMed ID: 12535528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIP140 and LCoR expression in gastrointestinal cancers.
    Triki M; Ben Ayed-Guerfali D; Saguem I; Charfi S; Ayedi L; Sellami-Boudawara T; Cavailles V; Mokdad-Gargouri R
    Oncotarget; 2017 Dec; 8(67):111161-111175. PubMed ID: 29340045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.
    Vattai A; Cavailles V; Sixou S; Beyer S; Kuhn C; Peryanova M; Heidegger H; Hermelink K; Mayr D; Mahner S; Dannecker C; Jeschke U; Kost B
    Oncotarget; 2017 Dec; 8(62):105356-105371. PubMed ID: 29285256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corepressor recruitment by agonist-bound nuclear receptors.
    White JH; Fernandes I; Mader S; Yang XJ
    Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.
    Jakobsson T; Osman W; Gustafsson JA; Zilliacus J; Wärnmark A
    Biochem J; 2007 Jul; 405(1):31-9. PubMed ID: 17391100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.
    Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH
    J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer.
    Chan CM; Lykkesfeldt AE; Parker MG; Dowsett M
    Clin Cancer Res; 1999 Nov; 5(11):3460-7. PubMed ID: 10589759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of RIP140.
    Wei LN; Farooqui M; Hu X
    J Biol Chem; 2001 May; 276(19):16107-12. PubMed ID: 11278635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.
    Lapierre M; Bonnet S; Bascoul-Mollevi C; Ait-Arsa I; Jalaguier S; Del Rio M; Plateroti M; Roepman P; Ychou M; Pannequin J; Hollande F; Parker M; Cavailles V
    J Clin Invest; 2014 May; 124(5):1899-913. PubMed ID: 24667635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140.
    Tazawa H; Osman W; Shoji Y; Treuter E; Gustafsson JA; Zilliacus J
    Mol Cell Biol; 2003 Jun; 23(12):4187-98. PubMed ID: 12773562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition.
    Castet A; Boulahtouf A; Versini G; Bonnet S; Augereau P; Vignon F; Khochbin S; Jalaguier S; Cavaillès V
    Nucleic Acids Res; 2004; 32(6):1957-66. PubMed ID: 15060175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
    Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
    Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
    Schaufele F
    Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes.
    Docquier A; Harmand PO; Fritsch S; Chanrion M; Darbon JM; Cavaillès V
    Clin Cancer Res; 2010 Jun; 16(11):2959-70. PubMed ID: 20410059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.